Neil Wilkie is the founder of Mironid. Mironid has raised $44M in total funding. Latest round: Series A. Based in Glasgow, United Kingdom.
Neil Wilkie is associated with Mironid, a University of Strathclyde spin-out biopharmaceutical company focused on developing small-molecule therapeutics for autosomal dominant polycystic kidney disease (ADPKD). He publicly announced Mironid's Series A extension in 2023, which brought total financing to £35 million.
Full founder directory · Investor directory · Company funding database · Fundraising library